SYDNEY, December 9, 2022 – George Clinical announces that it has entered into a sale agreement with Hillhouse, a global investment firm with deep experience in partnering with and supporting healthcare businesses. The transaction will allow George Clinical to continue a path of rapid global expansion, leadership in Asia-Pacific clinical research services, and will provide considerable […]
Read More
George Clinical Represented at AusBiotech 2022 Conference in Perth. Australia is a world-leading location for the life sciences and has been ranked among the top five in biotechnology innovation for the third consecutive year. AusBiotech is Australia’s life sciences organization, working on behalf of a well-connected network of over 3,000 members for more than 35 […]
Read MoreOVERLAND PARK, Ks., October 25, 2022 – George Clinical, in close collaboration with The George Institute for Global Health, has recently announced the recruitment of more than 5,000 patients in its ground-breaking, first of its kind, Global Kidney Patient Trials Network (GKPTN) which will accelerate treatments for kidney disease. The concept for the GKPTN is […]
Read MoreBEIJING, September 7, 2022 – George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the organization’s team in China with the addition of Helen Xu as Project Director and Cell Gene Therapy Head. She will be based in Beijing and joins a rapidly growing team responsible […]
Read MoreThat leaves 80% of mBC patients with fewer treatment options. However, research has shown that 55%-60% of these actually express low levels of HER2, and this is the category that Destiny-04 targeted, demonstrating that the legacy cutoff point to determine HER2 positivity can now be extended. These results establish HER2-low metastatic breast cancer as a […]
Read MoreGillian Ryan joined George Clinical in the spring of 2021 with over 20 years of experience in the pharmaceutical industry including experience working in, and with, large pharma companies and clinical research organizations, across all phases of drug development and many therapeutic areas. Gillian’s experience spans both project operations and medical affairs and she holds […]
Read MoreIBM recently highlighted the success George Clinical has enjoyed over the past several years leveraging the firm as a data, analytics and technology partner. The white paper, “Achieving Healthy CRO Growth Through Agility” was published with input from George Clinical Head of Data Management, Ullas Arabhavi. The paper describes how nearly a decade ago, the […]
Read More
COVID era innovations will help shape the future for more equitable representation. Oncology professionals from around the world attended the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in June, one of the largest oncology research conferences of the year. Researchers presented breakthrough clinical trial data including new treatment options, symptom management and research […]
Read MoreGeorge Clinical announces that it has achieved a Bronze Medal from EcoVadis, the world’s most trusted provider of business sustainability ratings. This is the first time the organization has pursued certification and earned a medal from EcoVadis. An EcoVadis Rating validates the organization’s business sustainability commitments and performance. George Clinical’s score places the company in […]
Read MoreA new multi-faceted partnership supported by George Clinical will move to the forefront of the cancer treatment revolution. The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub building links from research through to the clinic; creating jobs and changing lives. Over the past decade, immunotherapy and other […]
Read More
